These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7289718)

  • 1. [An investigation of the antibacterial activity of cefoxitin against anaerobic and aerobic bacteria in vitro (author's transl)].
    Babić I; Jelić I; Stanojević D
    Lijec Vjesn; 1980; 102(7-8):414-6. PubMed ID: 7289718
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the activity of cefoxitin against enterobacteriaceae and staphylococcus aureus in vitro (author's transl)].
    Krasemann C; Mohr G
    Arzneimittelforschung; 1977; 27(11):2029-31. PubMed ID: 579995
    [No Abstract]   [Full Text] [Related]  

  • 3. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of anaerobic bacteria to cofoxitin and related compounds.
    Bach VT; Roy I; Thadepalli H
    Antimicrob Agents Chemother; 1977 May; 11(5):912-3. PubMed ID: 879743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of mezlocillin against anaerobic bacteria.
    Sedallian A
    Chemioterapia; 1987 Jun; 6(2 Suppl):72-3. PubMed ID: 3509529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical findings of cefoxitin in the treatment of obstetric and gynecological infections (author's transl)].
    Hayasaki M; Iwasa SU; Noda K; Yamada Y; Ito K; Iida M; Chin C
    Jpn J Antibiot; 1982 Jan; 35(1):189-201. PubMed ID: 7069930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 8. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M; Navarra A; Bono L; Concia E
    J Chemother; 1989 Jul; 1(4 Suppl):101-2. PubMed ID: 16312323
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE; Slocombe B
    J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative activity of cefsulodin against anaerobic bacteria of clinical interest: synergy with cefoxitin.
    Watt B; Brown FV
    J Antimicrob Chemother; 1981 Mar; 7(3):269-78. PubMed ID: 6974166
    [No Abstract]   [Full Text] [Related]  

  • 16. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effect of new fluoroderivatives of piperazinol-quinoline on clinical strains of aerobic and anaerobic bacteria].
    Dzierzanowska D; Ukraiński W; Piotrowska E; Kazmirowska Z; Pykiel M
    Pol Tyg Lek; 1986 Sep; 41(37):1180-3. PubMed ID: 3822880
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'In-vitro' interaction of cefoxitin with other antimicrobial agents against enterobacteriaceae.
    Olay T; de Vicente MV; Rodríguez A
    J Antimicrob Chemother; 1981 Jul; 8(1):73-8. PubMed ID: 7251541
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro activity of the combination of daptomycin and metronidazole against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus spp., and Bacteroides spp.
    Werner H; Nagy E; Heizmann WR
    J Chemother; 1989 Jul; 1(4 Suppl):207-8. PubMed ID: 16312371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.